Birgitte Vrou Offersen

10PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Anthropology of gender and sexualityRadiation therapyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 23, 2026
Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1.

|Nov 26, 2025
BiGART 2025 - the 25th Acta Oncologica Symposium.

Jens Overgaard, Morten Høyer, Birgitte Vrou Offersen

|Oct 02, 2025
Patient reported respiratory symptoms and lung radiation doses 11 years after loco-regional breast cancer radiation therapy in the DBCG RT Nation Study.

Maja Bendtsen Sharma, Lasse Hindhede Refsgaard, Elisabeth Bendstrup

|Apr 22, 2025
Statin Therapy in Early Breast Cancer: The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo.

Signe Borgquist, Maj-Britt Jensen, Cecilie Linea Bendorff

|Oct 05, 2023
Think big-think BiGART. The 21st Acta Oncologica Symposium-BiGART 2023.

Jesper Grau Eriksen, Birgitte Vrou Offersen, Morten Høyer

|Jul 20, 2023
Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic.

Oluwadamilola T Oladeru, Samantha A Dunn, Jian Li

Pageof 2

Frequent Collaborators

5 joint publications

Jens Overgaard

3 joint publications

Maj-Britt Jensen

2 joint publications

Lise B J Thorsen

2 joint publications

Jan Alsner